EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:231601 - trastuzumab
| ChEBI ID | CHEBI:231601 |
| ChEBI Name | trastuzumab |
| Stars | |
| Definition | Trastuzumab is a HER2/neu Receptor Antagonist. |
| Submitter | ruixy |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| trastuzumab (CHEBI:231601) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab (CHEBI:231601) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| trastuzumab beta | WHO MedNet |
| Synonyms | Source |
|---|---|
| 4D5V8 | ChEMBL |
| ABP 980 | ChEMBL |
| ABP-980 | ChEMBL |
| ABP980 | ChEMBL |
| Abp-980 (trastuzumab biosimilar) | ChEMBL |
| Bmab-200 | ChEMBL |
| Brand Names | Source |
|---|---|
| Herceptin | ChEMBL |
| Herwenda | ChEMBL |
| Kadcyla | ChEMBL |
| Trastuzumab component of herceptin hylecta | ChEMBL |
| Trastuzumab component of phesgo | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| CAS:180288-69-1 | SUBMITTER |